Product information and disease descriptionProduct descriptionProduct information
Indication
4 evidence topics · 6 sources
First-line metastatic uveal melanoma, in combination with crizotinib
Product information and disease descriptionProduct descriptionProduct information
4 evidence topics · 6 sources